entity

UPS

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about UPS: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

8Connections

14Hypotheses

1Analyses

7Outgoing

1Incoming

6Experiments

1Debates

No AI portrait yet

Wiki Pages (2)

Knowledge base pages for this entity

Ubiquitin-Proteasome System (UPS) Therapeutics: Investment Landscape Analysis

investment · 675 words

→

Ubiquitin-Proteasome System (UPS) Neurons

cell · 605 words

→

Outgoing (7)

Target	Relation	Type	Str
Protein Turnover	regulates	process	0.95
Signaling	regulates	process	0.95
Disease-Associated Proteins	degrades	protein	0.88
proteostasis network	modulates	process	0.70
proteostasis	regulates	process	0.70
AUTOPHAGY	participates_in	pathway	0.64
ferroptosis	regulates	phenotype	0.56

Incoming (1)

Source	Relation	Type	Str
P62	regulates	protein	0.72

Targeting Hypotheses (14)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
Closed-loop transcranial focused ultrasound targeting EC-II	0.958	Alzheimer's disease	Circuit-level neural dynamics in neurode
Endosomal trafficking defects are the common upstream lesion	0.730	neurodegeneration	What determines the temporal sequence of
APOE4-driven pericyte injury/senescence is an upstream drive	0.720	neurodegeneration	Does pericyte senescence drive BBB break
TNF-α/IL-1β-Cx43 Hemichannel Axis as Upstream Link Between S	0.663	cell biology	What is the relative contribution of con
Lysosomal pH Restoration Upstream of TFEB	0.619	neurodegeneration	Does TFEB dysfunction cause neurodegener

Basal forebrain NGF/TrkA trophic failure is an upstream trig	0.610	neurodegeneration	What determines the temporal sequence of
microglial priming as a partially upstream causal node rathe	0.604	neurodegeneration	Microglial Priming as Upstream Causal No
Stratified falsifiers should govern Microglial Priming as Up	0.591	neurodegeneration	Microglial Priming as Upstream Causal No
Upstream restoration of glial lipid efflux and apoE lipidati	0.584	molecular biology	Does APOE4's reduced lipid-binding direc
NLRP3 Inflammasome Blockade as Upstream Intervention to Prev	0.566	neurodegeneration	Why have numerous phase 3 clinical trial
High baseline tau and ISR activation may lower the effective	0.510	neurodegeneration	-
Parthenolide perturbs adenosine transport or metabolism upst	0.506	neuropharmacology	How does parthenolide specifically modul
SREBP-2 Upstream Modulation for APOE4 Lipidation Enhancement	0.453	molecular biology	Is APOE4's reduced lipid binding pathoge
cGAS Inhibitors for ALS Therapeutics: Targeting Upstream mtD	0.380	neuroinflammation	How does chronic cGAS/STING activation d

Mentioning Analyses (1)

Scientific analyses that reference this entity

Why have numerous phase 3 clinical trials failed despite advances in understandi

neurodegeneration | 2026-04-12 | 1 hypotheses Top: 0.566

Experiments (6)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Model	Status	Est. Cost
Plant-based dietary patterns and Alzheimer's disease risk in multiethn	clinical	Alzheimer's disease and relate	0.950	human patients	proposed	N/A
Network pharmacology analysis of QTJD active compounds and pathways	exploratory	Mycoplasma pneumoniae pneumoni	0.900	computational network analysis	proposed	N/A
Molecular characterization of RBG-NLRP3 binding interaction	exploratory	atherosclerosis	0.900	purified proteins and molecula	proposed	N/A
Leukocyte gene expression analysis in COVID-19 patients	exploratory	COVID-19	0.900	human leukocytes from COVID-19	proposed	N/A
RBG effects on macrophage polarization and foam cell formation	exploratory	atherosclerosis	0.850	primary macrophages	proposed	N/A
Transcriptomic analysis of RBG effects on inflammatory gene expression	exploratory	atherosclerosis	0.800	ApoE-/- mice and cell cultures	proposed	N/A

Related Papers (8)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year
Protective Role of Purslane Supplementation Against Cadmium-Induced Renal and Gi [PMID:40877613]	Alsubaie N, Abd-Elhakim YM, Mohamed AA,	Biol Trace Elem Res	2026
Ginsenoside Rg5 inhibits colorectal cancer, at least partially by blocking the l [PMID:41639226]	Guo X, Sun R, Su Y, Qin Q, Liu Y et al.	Sci Rep	2026
Real-time visualization of drug-target interactions in native subcellular microe [PMID:41756019]	Wang R, Yuan Y, Shao H, Sun Y, Lai C et	J Pharm Anal	2026
P-tau217 correlates with neurodegeneration in Alzheimer's disease, and targeting [PMID:38513667]	Zhang D, Zhang W, Ming C, Gao X, Yuan H,	Neuron	2024
The necroptosis cell death pathway drives neurodegeneration in Alzheimer's disea [PMID:38852117]	Balusu S, De Strooper B	Acta neuropathologica	2024
Insulin Resistance and Diabetes Mellitus in Alzheimer's Disease. [PMID:34069890]	Burillo J, Marqués P, Jiménez B, Gonzále	Cells	2021
Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in tra [PMID:17021169]	["Oakley, Holly", "Cole, Sarah L", "Loga	The Journal of neuroscience :	2006
The amyloid hypothesis of Alzheimer's disease: progress and problems on the road [PMID:12130773]	["Hardy, John", "Selkoe, Dennis J"]	Science (New York, N.Y.)	2002

Debates (1)

Multi-agent debates referencing this entity

Why have numerous phase 3 clinical trials failed despite advances in understandi

closed · Rounds: 5 · Score: 0.67 · 2026-04-12

Related Research

Hypotheses and analyses mentioning UPS in their description or question text

Basal forebrain NGF/TrkA trophic failure is an upstream trigger that makes choli

Score: 0.610 · neurodegeneration · 2026-04-25

Loss of retrograde NGF-TrkA support could destabilize basal-forebrain cholinergic neurons early, lowering cortical acety

microglial priming as a partially upstream causal node rather than a pure diseas

Score: 0.604 · neurodegeneration · 2026-04-28

The debate supports carrying forward microglial priming as a partially upstream causal node rather than a pure disease-s

Stratified falsifiers should govern Microglial Priming as Upstream Causal Node A

Score: 0.591 · neurodegeneration · 2026-04-28

Claims from this analysis should be evaluated across TREM2, CX3CR1, C1QA, C1QB, C1QC; pooled effects are insufficient wh

Upstream restoration of glial lipid efflux and apoE lipidation will outperform d

Score: 0.584 · molecular biology · 2026-04-24

As a translational thesis, the debate supports prioritizing upstream correction of glial lipid handling over blunt direc

NLRP3 Inflammasome Blockade as Upstream Intervention to Prevent SASP Amplificati

Score: 0.566 · neurodegeneration · 2026-04-16

## Mechanistic Overview NLRP3 Inflammasome Blockade as Upstream Intervention to Prevent SASP Amplification starts from t

Parthenolide perturbs adenosine transport or metabolism upstream of ADORA2A

Score: 0.506 · neuropharmacology · 2026-04-25

Covalent modulation of transporters or metabolic enzymes changes local receptor occupancy in a context-dependent manner.

SREBP-2 Upstream Modulation for APOE4 Lipidation Enhancement

Score: 0.453 · molecular biology · 2026-04-21

## Mechanistic Overview SREBP-2 Upstream Modulation for APOE4 Lipidation Enhancement starts from the claim that modulati

cGAS Inhibitors for ALS Therapeutics: Targeting Upstream mtDNA Recognition

Score: 0.380 · neuroinflammation · 2026-04-27

The cGAS-STING pathway drives neuroinflammation in ALS through aberrant recognition of cytoplasmic mitochondrial DNA rel